InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Wednesday, 07/03/2019 11:40:29 AM

Wednesday, July 03, 2019 11:40:29 AM

Post# of 1228
News: $ZIOP Ziopharm Oncology Names NCI's Dr. Drew Deniger to Direct TCR-T Cell Therapy Program

BOSTON, July 03, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (“Ziopharm” or “the Company”) (Nasdaq:ZIOP), today announced Drew Deniger, Ph.D., will join Ziopharm from the National Cancer Institute (NCI) to lead the company’s program to genetically...

In case you are interested Ziopharm Oncology Names NCI's Dr. Drew Deniger to Direct TCR-T Cell Therapy Program
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TCRT News